Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Anomalies have been identified with the clinac collimator and couches that can result in small patient or field positioning errors that may adversely affect high - dose treatments requiring small positioning tolerances such as stereotactic radiosurgery (srs) and stereotactic radiotherapy (srt). refer to 'c- series clinacs when used for hypo-fractioned radiotherapy' dated 06/23/2010 for further information.